Curis
CRIS
#10201
Rank
HK$0.13 B
Marketcap
HK$10.51
Share price
0.00%
Change (1 day)
-65.81%
Change (1 year)

Curis (CRIS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$0.32 Billion

According to Curis's latest financial reports the company's total liabilities are HK$0.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Curis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.36 B-18.45%
2023-12-31HK$0.44 B-7.56%
2022-12-31HK$0.48 B-12.81%
2021-12-31HK$0.55 B-2.27%
2020-12-31HK$0.57 B6.27%
2019-12-31HK$0.53 B63.97%
2018-12-31HK$0.32 B-15.76%
2017-12-31HK$0.38 B76.16%
2016-12-31HK$0.22 B-6.42%
2015-12-31HK$0.23 B-7.3%
2014-12-31HK$0.25 B-7.28%
2013-12-31HK$0.27 B-0.2%
2012-12-31HK$0.27 B326.65%
2011-12-31HK$64.49 M61.51%
2010-12-31HK$39.93 M69.03%
2009-12-31HK$23.62 M10.88%
2008-12-31HK$21.3 M-60.81%
2007-12-31HK$54.36 M-57.31%
2006-12-31HK$0.12 B-28.33%
2005-12-31HK$0.17 B20.2%
2004-12-31HK$0.14 B13.03%
2003-12-31HK$0.13 B-61.8%
2002-12-31HK$0.34 B0.38%
2001-12-31HK$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Exelixis
EXEL
HK$5.15 B 1,465.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.83 B 1,975.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
HK$0.62 B 91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.38 B 18.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 273,062.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.44 B 184,840.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$0.10 B-68.55%๐Ÿ‡บ๐Ÿ‡ธ USA